Actions of anticholinesterase agents upon ganglionic transmission in the dog.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002714:Chlorisondamine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000502:physiology; D004285:Dogs; D004558:Electric Stimulation; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008464:Mecamylamine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology*; D013233:Stellate Ganglion / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*
D001713:Biphenyl Compounds; D002800:Cholinesterase Inhibitors; D006584:Hexamethonium Compounds; D010276:Parasympatholytics; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D002802:Cholinesterases; D002714:Chlorisondamine